AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSL LIMITED

255.400

-4.260-1.64%

Volume:471.21K

Turnover:120.60M

Market Cap:123.67B

PE:28.54

High:259.200

Open:258.750

Low:255.040

Close:259.660

Loading ...

Overview Company News Filings

Why did the ASX 200 go backwards in February?

BlackRock to reassess Australian exposure amid stretched valuations, weak growth

Large cap reporting season update: Defensive stocks doing well

BRIEF-CSL Says Swissmedic Approves Andembry To Prevent Recurrent Attacks Of Hereditary Angioedema

CSL Ltd - Swissmedic Approves CSL Behring’s Andembry (Garadacimab) for Prevention of Recurrent Attacks of Hereditary Angioedema

THOMSON REUTERS

CSL shares: Buy, sell or hold in 2025?

3 super strong ASX 200 blue chip shares to buy for your SMSF

Is Carlisle Companies Incorporated (NYSE:CSL) Trading At A 27% Discount?

Simply Wall St.

This week’s Hot Stock tip is perfect way to pounce on RBA cut – but have an exit plan too

The Market Herald

CSL’s mixed half-year: plasma strength offsets vaccine weakness, bright outlook maintained

Should you buy the dip on ASX healthcare stocks CSL, Cochlear and Pro Medicus?

CSL First Half 2025 Earnings: EPS Misses Expectations

Simply Wall St.

Top brokers name 3 ASX shares to buy next week

Here's What Analysts Are Forecasting For CSL Limited (ASX:CSL) After Its Half-Yearly Results

Simply Wall St.

These ASX 200 shares could rise 20% to 40%

European Commission Approves CSL and Arcturus Therapeutics' Kostaive®, the First Self-Amplifying Mrna Covid-19 Vaccine

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/CSL.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CSL.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":255.4,"timestamp":1741583520000,"preClose":259.66,"halted":0,"volume":471213,"delay":0,"changeRate":-0.016406,"change":-4.26,"floatShares":483945244,"shares":484206716,"eps":8.947984,"lyrEps":8.64302,"pbRate":4.22,"amount":120602603,"amplitude":0.016021,"volumeRatio":0.588905,"dividePrice":4.345325,"prevYearClose":279.35,"fiveDayClose":259.925,"twentyDayClose":268.199},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483945244,"roa":"6.61%","roe":"14.35%","lyrEps":8.64302,"volumeRatio":0.588905,"shares":484206716,"dividePrice":4.345325,"high":259.2,"amplitude":0.016021,"preClose":259.66,"low":255.04,"week52Low":251.03,"pbRate":"4.22","psRate":"5.14","week52High":308.846,"institutionHeld":0,"latestPrice":255.4,"committee":0.701149,"eps":8.947984085048288,"divideRate":0.01709,"volume":471213,"delay":0,"ttmEps":8.947984085048288,"open":258.75,"prevYearClose":279.35,"prevWeekClose":257.604,"prevMonthClose":258.507,"prevQuarterClose":279.35,"fiveDayClose":259.925,"twentyDayClose":268.199,"sixtyDayClose":279.777},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","defaultRemindTime":1741561200000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"},{"date":"2025-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739228400000,"name":null,"time":"","dateTimestamp":1739192400000,"actualEps":null},{"date":"2024-09-09","symbol":"CSL.AU","amount":1.45,"announcedDate":"2024-08-13","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-10","defaultRemindTime":1725840000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-02","payableDate":"2024-09-10","currency":"USD","dateTimestamp":1725804000000,"payDate":"2024-10-02"},{"date":"2024-08-13","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723507200000,"name":null,"time":"","dateTimestamp":1723471200000,"actualEps":null},{"date":"2024-03-11","symbol":"CSL.AU","amount":1.19,"announcedDate":"2024-02-13","type":"dividend","market":"AU","newRecordDate":"2024-03-12","defaultRemindTime":1710111600000,"name":"CSL 公司","recordDate":"2024-04-03","payableDate":"2024-03-12","currency":"USD","dateTimestamp":1710075600000,"payDate":"2024-04-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514934053","title":"Why did the ASX 200 go backwards in February?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514934053","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514934053?lang=en_us&edition=fundamental","pubTime":"2025-02-28 11:07","pubTimestamp":1740712025,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index(ASX: XJO) is down 0.7% in afternoon trade on Friday. Barring a last minute miracle, that means the benchmark Aussie index will have gone backwards over the month. The ASX 200 clo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/28/why-did-the-asx-200-go-backwards-in-february/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XJO.AU","BK7135","BK7141","BK7505","BK7501","BK7067","BK7095","BK7507","XKO.AU","CBA.AU","A2M.AU","CSL.AU","BHP.AU","BK7508","BK7511","XAO.AU"],"gpt_icon":0},{"id":"2514103338","title":"BlackRock to reassess Australian exposure amid stretched valuations, weak growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2514103338","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514103338?lang=en_us&edition=fundamental","pubTime":"2025-02-27 11:29","pubTimestamp":1740626993,"startTime":"0","endTime":"0","summary":"that 4% unemployment rate obviously is causing them a bit of consternation,\" said Craig Vardy, BlackRock's Australasia head of fixed income.That would reduce the prospect for more rate cuts to stimulate growth for Australia's households, he added.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI06Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861249.SGD","BK4135","LU1280957306.USD","BK7508","LU2505996509.AUD","BK4567","BK7095","BK4534","BK7511","BHP.AU","LU0742537680.HKD","BK4533","LU0980610538.SGD","BK4588","IE00BDGV0183.EUR","LU2430703095.HKD","BK7507","IE00BVYPNW00.USD","BK7135","BK7501","LU2592432038.USD","LU0731783048.USD","LU2430703178.SGD","LU0772969993.USD","LU2264538146.SGD","LU1074936037.SGD","LU0208291251.USD","CBA.AU","LU1481011671.HKD","BK7067","LU0130102774.USD","BK4504","LU1481011911.USD","IE00B64PRP62.GBP","LU0640476718.USD","IE00BGHQF748.EUR","BLK","IE00BGHQF631.EUR","CSL.AU","LU1670627923.USD","BK4581","LU0320765489.SGD","LU1291159041.SGD","LU1670628061.USD","LU1599440770.SGD","IE00B3PB1722.GBP","BK4535","LU1509826696.USD","IE00BVYPNV92.GBP","LU0731783394.SGD"],"gpt_icon":1},{"id":"2514672815","title":"Large cap reporting season update: Defensive stocks doing well","url":"https://stock-news.laohu8.com/highlight/detail?id=2514672815","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514672815?lang=en_us&edition=fundamental","pubTime":"2025-02-27 10:01","pubTimestamp":1740621677,"startTime":"0","endTime":"0","summary":"In our latest reporting season coverage, I discuss how investors have been rotating away from momentum-driven stocks with high valuations towards more defensive stocks with strong fundamentals. I also share my thoughts on the performance of the major banks and iron ore miners as well as some of the key stocks in IML’s portfolios including Brambles , Charter Hall Retail REIT , CSL  and Amcor .Lightly edited transcript – Recorded on 24 February. Jason Guthrie: Hello and welcome to Navigating the Noise, a podcast by Natixis Investment Managers, where we bring you insights from our global collective of experts to help you make better investment decisions. I’m Jason Guthrie, and today I’m joined by Michael O’Neill, portfolio manager on IML’s large cap team. Now, Mike has been with the firm for close to 15 years and co-manages a number of strategies, including the Equity Income Fund and also the Industrial Share Funds.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/large-cap-reporting-season-update-defensive-stocks-doing-well","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/large-cap-reporting-season-update-defensive-stocks-doing-well","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["LU2111349929.HKD","LU2028103732.USD","LU0320765059.SGD","LU1301847155.USD","IE00B4YYXB79.USD","SG9999014898.SGD","LU2458330243.SGD","LU2491050071.SGD","LU2552382215.SGD","BXB.AU","LU2720916845.USD","IE00BK4W5L77.USD","BK4579","AMC.AU","LU0949170426.SGD","CSL.AU","BHP.AU","LU0289941410.SGD","LU1340139317.AUD","LU0109391861.USD","LU0265550946.USD","LU0308772762.SGD","LU1496350171.SGD","NAB.AU","IE00BMPRXR70.SGD","LU2065169927.USD","LU1066051498.USD","LU1633808545.USD","CBA.AU","LU2361044865.SGD","LU2286300806.USD","LU1778281490.HKD","IE00B5949003.HKD","LU1974910355.USD","SG9999002224.SGD","LU0314106906.USD","CQR.AU","LU1046421795.USD","LU1066051225.USD","LU0823434740.USD","LU0234572021.USD","IE0004086264.USD","LU1116320901.HKD","LU0289961442.SGD","WBC.AU","LU2491049909.HKD","LU1032466523.USD","BK4598","IE00BFSS7M15.SGD"],"gpt_icon":1},{"id":"2514890782","title":"BRIEF-CSL Says Swissmedic Approves Andembry To Prevent Recurrent Attacks Of Hereditary Angioedema","url":"https://stock-news.laohu8.com/highlight/detail?id=2514890782","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514890782?lang=en_us&edition=fundamental","pubTime":"2025-02-27 08:41","pubTimestamp":1740616874,"startTime":"0","endTime":"0","summary":"BRIEF-CSL Says Swissmedic Approves Andembry To Prevent Recurrent Attacks Of Hereditary AngioedemaFeb 27  - CSL Ltd CSL.AX:SWISSMEDIC APPROVES CSL BEHRING'S ANDEMBRY  FOR PREVENTION OF RECURRENT ATTACKS OF HEREDITARY ANGIOEDEMAFurther company coverage: CSL.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PH1S3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","BK7511","BK7508","CSL.AU"],"gpt_icon":0},{"id":"2514886131","title":"CSL Ltd - Swissmedic Approves CSL Behring’s Andembry (Garadacimab) for Prevention of Recurrent Attacks of Hereditary Angioedema","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886131","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514886131?lang=en_us&edition=fundamental","pubTime":"2025-02-27 03:14","pubTimestamp":1740597262,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH1S3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","CSL.AU","BK7501","BK7511","BK7067"],"gpt_icon":0},{"id":"2514080272","title":"CSL shares: Buy, sell or hold in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514080272","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514080272?lang=en_us&edition=fundamental","pubTime":"2025-02-25 10:28","pubTimestamp":1740450494,"startTime":"0","endTime":"0","summary":"CSL Ltd  shares are up 0.3% at $261.87 today, shaking off the broader market sell-down. This sees the company with a market cap of almost $127 billion, making it the third largest stock on the ASX. Over the past year, however, shares in the S&P/ASX 200 Index biotech stock have trailed the benchmark, sliding 9%, while the ASX 200 has gained 8%. Though those losses were somewhat moderated by the $4.25 a share in unfranked dividends CSL paid out  over the year. But with CSL shares continuing to struggle in 2025, is the biotech stock one to buy, sell, or hold onto?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/25/csl-shares-buy-sell-or-hold-in-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CSL.AU","BK4086","LU1169590202.USD","BK7508","XJO.AU","BK7501","BK7067","BK7511","SG9999004303.SGD","CSL","SGXZ23171101.USD","LU0728928796.USD","LU1169589451.USD"],"gpt_icon":0},{"id":"2513324646","title":"3 super strong ASX 200 blue chip shares to buy for your SMSF","url":"https://stock-news.laohu8.com/highlight/detail?id=2513324646","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513324646?lang=en_us&edition=fundamental","pubTime":"2025-02-22 06:03","pubTimestamp":1740175438,"startTime":"0","endTime":"0","summary":"There are plenty of ASX 200 blue chip shares to choose from on the local share market for your self-managed super fund . But which ones could be buys?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/22/3-super-strong-asx-200-blue-chip-shares-to-buy-for-your-smsf/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4198","BK4533","LU2471134952.CNY","BK7508","LU1868836914.USD","LU2237443549.SGD","IE00BFXG1179.USD","LU1868837300.USD","IE0004086264.USD","BK7044","LU2237443622.USD","BK4585","BK7511","LU0012050646.USD","LU0106831901.USD","LU2471134879.HKD","BK4550","LU2237443382.USD","LU2750360997.AUD","IE00BSNM7G36.USD","BK7067","BK4127","TWE.AU","HAE","LU1668664300.SGD","LU2237443895.HKD","LU1169589451.USD","LU1169590202.USD","LU2750360641.GBP","LU1868836591.USD","IE0002270589.USD","LU1791807156.HKD","LU2237438978.USD","BK4504","LU2471134796.USD","BK4552","LU0205193047.USD","LU0096364046.USD","LU2237443978.SGD","IE0004091025.USD","BK4516","LU0106261612.USD","CSL.AU","LU1868836757.USD","BK4588","BKW.AU","IE00B19Z3581.USD","IE00B64QTZ34.USD","LU2237443465.HKD","BK7505"],"gpt_icon":0},{"id":"2512482941","title":"Is Carlisle Companies Incorporated (NYSE:CSL) Trading At A 27% Discount?","url":"https://stock-news.laohu8.com/highlight/detail?id=2512482941","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512482941?lang=en_us&edition=fundamental","pubTime":"2025-02-19 22:25","pubTimestamp":1739975143,"startTime":"0","endTime":"0","summary":"Key Insights Using the 2 Stage Free Cash Flow to Equity, Carlisle Companies fair value estimate is US$484 Carlisle...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/is-carlisle-companies-incorporated-nysecsl-trading-at-a-27-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FCF","BK7067","LU0728928796.USD","SGXZ23171101.USD","BK4100","BK4086","DCF","BK7511","BK7501","TV","BK4211","LU1169590202.USD","BK7508","NYSE","LU1169589451.USD","SG9999004303.SGD","CSL.AU","CSL"],"gpt_icon":0},{"id":"2512189536","title":"This week’s Hot Stock tip is perfect way to pounce on RBA cut – but have an exit plan too","url":"https://stock-news.laohu8.com/highlight/detail?id=2512189536","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512189536?lang=en_us&edition=fundamental","pubTime":"2025-02-18 12:40","pubTimestamp":1739853600,"startTime":"0","endTime":"0","summary":"This week’s HotCopper Hot Stock from Wealth Within analystsFil Tortevskiand Pedro Banales is one of the simplest sells on the ASX – and “everyone knows about it” – because it leads the bourse: Commonwealth Bank .Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.“The CBA has been the hot topic of recent weeks,” Mr Tortevski explained today.Importantly, the index leader is right in the middle of the rate cut storm coming through this week . “This bank is one of the biggest players there,” he added.Mr Tortevski explained it’s not a long hold though: “It’s a potential Hot Stock tip that has short-term potential… I’m not thinking long on CBA at all here, especially if we do go through another easing cycle shortly as well.”That warning proved prescient; CBA lost as much as 1.1% after the RBA’s Tuesday rate cut call, with much of the ASX dipping as it shaved value.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/this-weeks-hot-stock-tip-is-perfect-way-to-pounce-on-rba-cut-but-have-an-exit-plan-too-2025-02-18/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7508","CSL.AU","AMP.AU","BK7135","BK7112","CBA.AU","BK7501","BK7067","BK7511"],"gpt_icon":0},{"id":"2512972131","title":"CSL’s mixed half-year: plasma strength offsets vaccine weakness, bright outlook maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2512972131","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512972131?lang=en_us&edition=fundamental","pubTime":"2025-02-18 08:42","pubTimestamp":1739839369,"startTime":"0","endTime":"0","summary":"CSL  has posted its half-year results, delivering results that are best described as mixed. At the headline level, revenue climbed around five per cent, while net profit after tax and amortisation  also nudged upward in the low single digits. Beneath these top-line numbers, the company reported a robust rebound in plasma collections, which was offset by weaker sales of its Seqirus influenza vaccines. Despite these mixed signals, management has reaffirmed guidance for FY25, projecting 10-13 per cent NPATA earnings per share  growth and a five to seven per cent lift in revenue.From a valuation perspective, CSL trades on roughly 22× enterprise value/ earnings before interest and taxes  – reasonable, if not cheap, compared to historical averages for a company that has delivered consistent double-digit growth. High barriers to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/csl-s-mixed-half-year-plasma-strength-offsets-vaccine-weakness-bright-outlook-maintained","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/csl-s-mixed-half-year-plasma-strength-offsets-vaccine-weakness-bright-outlook-maintained","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7511","BK7501","BK7508","LU0728928796.USD","LU1169590202.USD","BK7067","SGXZ23171101.USD","LU1169589451.USD","CSL.AU","CSL","SG9999004303.SGD","BK4086"],"gpt_icon":0},{"id":"2512979589","title":"Should you buy the dip on ASX healthcare stocks CSL, Cochlear and Pro Medicus?","url":"https://stock-news.laohu8.com/highlight/detail?id=2512979589","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512979589?lang=en_us&edition=fundamental","pubTime":"2025-02-18 05:00","pubTimestamp":1739826009,"startTime":"0","endTime":"0","summary":"In this article, we’ll investigate the best and worst bits of the recent first-half financial year 2025 results  releases of three of the ASX’s premier healthcare companies, CSL Limited , Cochlear , and Pro Medicus .We’ll also check out the market’s response to the results, including the dip in each of their share prices, as well as all the changes in major brokers’ ratings and target prices. Do the experts think you should buy the dip on these blue-chip ASX healthcare stocks?CSL is a true Australian success story, having grown from humble beginnings as Commonwealth Serum Laboratories founded in 1916, to a globally significant healthcare company. It operates across the world with divisions including CSL Behring , CSL Seqirus , and CSL Vifor .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/should-you-buy-the-dip-on-asx-healthcare-stocks-csl-cochlear-and-pro-medicus","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/should-you-buy-the-dip-on-asx-healthcare-stocks-csl-cochlear-and-pro-medicus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["LU1868837136.USD","COH.AU","LU0205194284.USD","LU0728928796.USD","BK4086","LU1668664300.SGD","LU2237438978.USD","SGXZ23171101.USD","XKO.AU","LU2471134952.CNY","IE00B64QTZ34.USD","LU0106831901.USD","LU2237443978.SGD","BK4585","LU2237443382.USD","LU2471134879.HKD","BK4550","LU0106261612.USD","BK7508","IE00B19Z3B42.SGD","LU0012050646.USD","LU1169589451.USD","IE00B19Z3581.USD","XJO.AU","BK7067","LU0061475181.USD","LU1868836591.USD","HAE","LU1868837300.USD","LU2237443549.SGD","LU1868836914.USD","PME.AU","LU2471134796.USD","BK7501","LU0205193047.USD","BK4552","XAO.AU","BK4504","LU1791807156.HKD","LU1868836757.USD","IE0004086264.USD","LU2237443465.HKD","BK4516","CSL","SG9999004303.SGD","BK7094","CSL.AU","LU2471134523.USD","BK4127","LU2750360641.GBP"],"gpt_icon":0},{"id":"2511981101","title":"CSL First Half 2025 Earnings: EPS Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2511981101","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511981101?lang=en_us&edition=fundamental","pubTime":"2025-02-16 06:45","pubTimestamp":1739659541,"startTime":"0","endTime":"0","summary":"CSL ( ASX:CSL ) First Half 2025 Results Key Financial Results Revenue: US$8.48b (up 5.3% from 1H 2024). Net income...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-first-half-2025-earnings-eps-misses-expectations","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL","CSL.AU"],"gpt_icon":0},{"id":"2511028036","title":"Top brokers name 3 ASX shares to buy next week","url":"https://stock-news.laohu8.com/highlight/detail?id=2511028036","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511028036?lang=en_us&edition=fundamental","pubTime":"2025-02-16 04:15","pubTimestamp":1739650500,"startTime":"0","endTime":"0","summary":"It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Her","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/16/top-brokers-name-3-asx-shares-to-buy-next-week-16-february-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU0061475181.USD","LU0098860793.USD","LU2237443978.SGD","BK4550","LU0795875086.SGD","BK7067","LU0971096721.USD","LU0795875169.SGD","LU1989772840.SGD","LU2089284900.SGD","LU1720051108.HKD","IE0004086264.USD","LU0096364046.USD","IE0002270589.USD","LU2237443465.HKD","LU2347655156.SGD","LU0912757837.SGD","LU2111349929.HKD","LU2357305700.SGD","LU1868836914.USD","LU2471134796.USD","IE00BZ1G4Q59.USD","IE0034235188.USD","BK4581","LU1868836591.USD","PME.AU","LU1868837136.USD","IE00BKVL7J92.USD","LU2750360997.AUD","LU2023251221.USD","BK4516","BK7511","LU1868836757.USD","CSL.AU","LU1162221912.USD","LU1668664300.SGD","LU0320765646.SGD","DMP.AU","LU1732800096.USD","BK7137","BK7501","BK4585","BK4588","IE0004091025.USD","LU0158827781.USD","LU2237443549.SGD","LU0225283273.USD","LU2028103732.USD","BK4552","LU2271345857.HKD"],"gpt_icon":1},{"id":"2511641338","title":"Here's What Analysts Are Forecasting For CSL Limited (ASX:CSL) After Its Half-Yearly Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2511641338","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511641338?lang=en_us&edition=fundamental","pubTime":"2025-02-15 07:48","pubTimestamp":1739576911,"startTime":"0","endTime":"0","summary":"CSL Limited  shareholders are probably feeling a little disappointed, since its shares fell 4.8% to AU$257 in the week after its latest half-year results. Revenues of US$8.5b were in line with forecasts, although statutory earnings per share  came in below expectations at US$4.13, missing estimates by 4.4%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for CSL. On the plus side, there w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-analysts-forecasting-csl-limited-234831917.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["CSL","BK7501","BK7067","LU0728928796.USD","LU1169590202.USD","CSL.AU","LU1169589451.USD","SGXZ23171101.USD","BK7508","BK7511","SG9999004303.SGD","BK4086"],"gpt_icon":0},{"id":"2511649874","title":"These ASX 200 shares could rise 20% to 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511649874","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511649874?lang=en_us&edition=fundamental","pubTime":"2025-02-15 05:34","pubTimestamp":1739568840,"startTime":"0","endTime":"0","summary":"If you are on the lookout for some big returns in 2025, then it could pay to listen to what analysts are saying about the ASX 200 shares in this article. That's because they have been named as buys an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/15/these-asx-200-shares-could-rise-20-to-40-4/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4550","LU2237443622.USD","BK4588","IE0004091025.USD","IE0004086264.USD","LU2237443978.SGD","LU2237443895.HKD","BK7097","BK4533","IE00BFXG1179.USD","BK4516","BK7067","BK4552","LU2750360641.GBP","LU0106831901.USD","LU2750360997.AUD","IE0034235188.USD","LU2237438978.USD","DYL.AU","BK7501","LU1791807156.HKD","BK7083","IE0002270589.USD","IE00B19Z3B42.SGD","LU2471134523.USD","BK4127","IE00B19Z3581.USD","BK7511","BK7508","BK4504","LU1668664300.SGD","LU2237443465.HKD","BK4585","IE00BSNM7G36.USD","LU2471134796.USD","BK7505","LU2471134879.HKD","LU2237443382.USD","CSL.AU","LU2237443549.SGD","LU2471134952.CNY","TWE.AU"],"gpt_icon":0},{"id":"2511660068","title":"European Commission Approves CSL and Arcturus Therapeutics' Kostaive®, the First Self-Amplifying Mrna Covid-19 Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2511660068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511660068?lang=en_us&edition=fundamental","pubTime":"2025-02-14 21:30","pubTimestamp":1739539804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nTUA2RQQ7G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7501","BK7067","CSL.AU","BK4139","ARCT"],"gpt_icon":0}],"pageSize":16,"totalPage":13,"pageCount":2,"totalSize":200}]}}